Hrzenjak, Andelko <br/><br/>
Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells.  [electronic resource] 

 -  Molecular cancer therapeutics  Sep 2006 
 - 2203-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-7163 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-05-0480  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Differentiation--drug effects<br/>Cell Growth Processes--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p21--biosynthesis<br/>Endometrial Neoplasms--drug therapy<br/>Female<br/>Histone Deacetylase 1<br/>Histone Deacetylase 2<br/>Histone Deacetylase Inhibitors<br/>Histone Deacetylases--biosynthesis<br/>Humans<br/>Immunohistochemistry<br/>RNA, Small Interfering--genetics<br/>Repressor Proteins--antagonists & inhibitors<br/>Sarcoma, Endometrial Stromal--drug therapy<br/>Tumor Cells, Cultured<br/>Valproic Acid--pharmacology